NUVL
Price
$80.89
Change
+$1.22 (+1.53%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
5.83B
62 days until earnings call
RVMD
Price
$40.51
Change
+$1.56 (+4.01%)
Updated
Sep 5, 04:59 PM (EDT)
Capitalization
7.57B
60 days until earnings call
Interact to see
Advertisement

NUVL vs RVMD

Header iconNUVL vs RVMD Comparison
Open Charts NUVL vs RVMDBanner chart's image
Nuvalent
Price$80.89
Change+$1.22 (+1.53%)
Volume$12.23K
Capitalization5.83B
Revolution Medicines
Price$40.51
Change+$1.56 (+4.01%)
Volume$26.94K
Capitalization7.57B
NUVL vs RVMD Comparison Chart in %
Loading...
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
NUVL vs. RVMD commentary
Sep 06, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is NUVL is a StrongBuy and RVMD is a Buy.

Interact to see
Advertisement
COMPARISON
Comparison
Sep 06, 2025
Stock price -- (NUVL: $79.67 vs. RVMD: $40.50)
Brand notoriety: NUVL and RVMD are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: NUVL: 100% vs. RVMD: 98%
Market capitalization -- NUVL: $5.83B vs. RVMD: $7.57B
NUVL [@Biotechnology] is valued at $5.83B. RVMD’s [@Biotechnology] market capitalization is $7.57B. The market cap for tickers in the [@Biotechnology] industry ranges from $101.56B to $0. The average market capitalization across the [@Biotechnology] industry is $1.88B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

NUVL’s FA Score shows that 0 FA rating(s) are green whileRVMD’s FA Score has 0 green FA rating(s).

  • NUVL’s FA Score: 0 green, 5 red.
  • RVMD’s FA Score: 0 green, 5 red.
According to our system of comparison, NUVL is a better buy in the long-term than RVMD.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

NUVL’s TA Score shows that 6 TA indicator(s) are bullish while RVMD’s TA Score has 5 bullish TA indicator(s).

  • NUVL’s TA Score: 6 bullish, 5 bearish.
  • RVMD’s TA Score: 5 bullish, 4 bearish.
According to our system of comparison, both NUVL and RVMD are a good buy in the short-term.

Price Growth

NUVL (@Biotechnology) experienced а +4.80% price change this week, while RVMD (@Biotechnology) price change was +6.66% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.44%. For the same industry, the average monthly price growth was +9.90%, and the average quarterly price growth was +31.78%.

Reported Earning Dates

NUVL is expected to report earnings on Nov 06, 2025.

RVMD is expected to report earnings on Nov 05, 2025.

Industries' Descriptions

@Biotechnology (+2.44% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
RVMD($7.57B) has a higher market cap than NUVL($5.83B). NUVL YTD gains are higher at: 1.776 vs. RVMD (-7.407). NUVL has higher annual earnings (EBITDA): -362.01M vs. RVMD (-883.71M). RVMD has more cash in the bank: 2.14B vs. NUVL (1.01B). NUVL (0) and RVMD (0) have equivalent revenues.
NUVLRVMDNUVL / RVMD
Capitalization5.83B7.57B77%
EBITDA-362.01M-883.71M41%
Gain YTD1.776-7.407-24%
P/E RatioN/AN/A-
Revenue00-
Total Cash1.01B2.14B47%
Total DebtN/A133M-
TECHNICAL ANALYSIS
Technical Analysis
NUVLRVMD
RSI
ODDS (%)
Bullish Trend 2 days ago
83%
N/A
Stochastic
ODDS (%)
Bearish Trend 2 days ago
84%
Bearish Trend 2 days ago
82%
Momentum
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
84%
MACD
ODDS (%)
Bullish Trend 2 days ago
84%
Bullish Trend 2 days ago
86%
TrendWeek
ODDS (%)
Bullish Trend 2 days ago
82%
Bullish Trend 2 days ago
79%
TrendMonth
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 2 days ago
79%
Advances
ODDS (%)
Bullish Trend 2 days ago
81%
Bullish Trend 3 days ago
80%
Declines
ODDS (%)
Bearish Trend 17 days ago
79%
Bearish Trend about 1 month ago
76%
BollingerBands
ODDS (%)
Bearish Trend 2 days ago
79%
Bearish Trend 2 days ago
90%
Aroon
ODDS (%)
Bearish Trend 2 days ago
87%
Bearish Trend 2 days ago
80%
View a ticker or compare two or three
Interact to see
Advertisement
NUVL
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
RVMD
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RWIAX72.280.34
+0.47%
American Funds Capital World Gr&Inc R1
OSPMX6.59N/A
N/A
Invesco SteelPath MLP Income R6
DDDCX19.44N/A
N/A
13D Activist C
VILSX36.94N/A
N/A
Value Line Select Growth Institutional
RPFGX75.62-1.06
-1.38%
Davis Financial A

NUVL and

Correlation & Price change

A.I.dvisor indicates that over the last year, NUVL has been loosely correlated with CGON. These tickers have moved in lockstep 55% of the time. This A.I.-generated data suggests there is some statistical probability that if NUVL jumps, then CGON could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To NUVL
1D Price
Change %
NUVL100%
+0.16%
CGON - NUVL
55%
Loosely correlated
+7.92%
ABCZF - NUVL
51%
Loosely correlated
N/A
CRNX - NUVL
51%
Loosely correlated
-1.15%
RVMD - NUVL
50%
Loosely correlated
-2.06%
IDYA - NUVL
50%
Loosely correlated
+0.27%
More